Danaher | DHR - Selling And Administration Expenses

Stock Price
222.00
Daily Change
3.11 1.42%
Monthly
-5.68%
Yearly
3.61%
Q1 Forecast
212.15

Danaher reported $2.03B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Agilent USD 428M 37M Sep/2025
Align Technology USD 417.8M 30.89M Sep/2025
Becton, Dickinson and Co. USD 1.37B 46M Sep/2025
Bio Techne USD 116.21M 80.43M Sep/2025
Bio-Rad Laboratories USD 207.7M 14.2M Jun/2025
Boston Scientific USD 1.74B 25M Sep/2025
Bruker USD 242.5M 11.1M Sep/2025
Charles River Laboratories USD 177.59M 8.23M Sep/2025
Danaher USD 2.03B 35M Dec/2025
Dentsply International USD 355M 21M Sep/2025
Edwards Lifesciences USD 514.6M 12.6M Sep/2025
ESCO Technologies USD 62.04M 3.88M Jun/2025
Exact Sciences USD 491.64M 35.94M Sep/2025
Fortive USD 427.6M 136.7M Sep/2025
Henry Schein USD 760M 17M Sep/2025
Hologic USD 2.5B 2.24B Dec/2025
Illumina USD 256M 59M Sep/2025
Intuitive Surgical USD 687.1M 113.8M Dec/2025
IQVIA Holdings USD 514M 5M Sep/2025
Keysight Technologies USD 399M 60M Sep/2025
Laboratory Of America USD 552.4M 26.9M Sep/2025
Medtronic 2.97B 159M Sep/2025
Mettler Toledo International USD 248.39M 1.09M Sep/2025
Myriad Genetics USD 129M 1.3M Sep/2025
Quest Diagnostics USD 501M 15M Sep/2025
Quidel USD 186.9M 16.8M Sep/2025
Repligen USD 73.66M 2.43M Sep/2025
Revvity USD 241.91M 9.6M Sep/2025
Roper Industries USD 841.6M 11.6M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Waters USD 214.23M 12.97M Sep/2025
Zimmer Biomet Holdings USD 811.4M 3.4M Sep/2025